Mon.Sep 16, 2024

article thumbnail

Q&A: The U.S. can, and should, do more on H5N1 bird flu, a top WHO official says

STAT

More work needs to be done by the agricultural sector to get to the bottom of — and put a stop to — transmission of H5N1 bird flu in dairy cattle in the United States, a senior World Health Organization official said over the weekend. Maria Van Kerkhove, the WHO’s acting director of epidemic and pandemic preparedness and prevention, said the world is watching how the U.S., with its advanced scientific expertise, is responding to this outbreak.

362
362
article thumbnail

Agility in action: 5 ways to fast-track your clinical trial

PharmaVoice

Five ways to beat study timeline pressures and get medicines to patients faster.

235
235
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pediatricians’ obesity guidelines rest on shaky evidence about eating disorder risks

STAT

To address soaring rates of childhood obesity, the American Academy of Pediatrics last year endorsed tactics it once considered risky.  “Watchful waiting” had been standard practice, in part from concern that a doctor’s focus on weight could inadvertently plant the seed for stigma or eating disorders like anorexia and bulimia.

362
362
article thumbnail

Biopharma prepares to pivot from China as Biosecure Act advances

PharmaVoice

After the House of Representatives passed the Biosecure Act last week, U.S. biotechs could be forced to cut ties with five Chinese contract partners.

162
162
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Opinion: What the doctors’ protests in India are missing

STAT

In early August, a doctor was raped and murdered in a Kolkata public hospital by a “ civic volunteer ” who was neither a patient nor a staff member. The crime has enraged and rattled the medical profession in India. For weeks now, doctors have been protesting throughout the country, demanding among other things “justice for the victim” and a safer work environment.

Hospitals 361
article thumbnail

The hunt for game-changers against the deadliest form of brain cancer

PharmaVoice

Treatments for glioblastoma have fallen short in the face of difficult challenges, but the pipeline is full of renewed attempts.

147
147

More Trending

article thumbnail

After the Lykos debacle, what’s next for psychedelic therapies?

Pharmaceutical Technology

While Lykos Therapeutics’ MDMA therapy was rejected by the FDA, psychedelic therapy advocates remain optimistic about the sector.

119
119
article thumbnail

STAT+: After 10 years of game-changing immunotherapies, a cancer conference celebrates — and sees more work to do

STAT

BARCELONA, Spain — Ten years ago, a new type of cancer treatment reached the market. It worked by rousing the body’s own immune cells to attack tumors. Within months, regulators had approved two of the treatments, at first for melanoma.   The story — and the transformative impact — of Bristol Myers Squibb’s Opdivo and Merck’s Keytruda are well known at this point.

Immunity 343
article thumbnail

AbbVie faulted for misleading ad featuring Serena Williams

pharmaphorum

FDA raps AbbVie for 'misleading' ad for migraine drug Ubrelvy featuring tennis star Serena Williams

119
119
article thumbnail

STAT+: Top staffer on drug pricing to depart Senate Finance Committee

STAT

WASHINGTON — Shawn Bishop, the Democratic staffer who drafted much of the drug pricing portion of the Inflation Reduction Act, is leaving the Senate Finance Committee next month, according to five sources familiar with the departure.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

One in five patients struggle to get medication

The Pharmacist

One in five (20.1%) patients in England had problems obtaining their prescription medication this summer, according latest Office of National Statistics (ONS) figures. However, 85% of adults using pharmacy services said they were ‘very satisfied’ or ‘satisfied’ with the service they received. This exceeded the 67.4% of adults who tried to contact their GP practice […] The post One in five patients struggle to get medication appeared first on The Pharmacist.

115
115
article thumbnail

The essential biotech updates of the day

STAT

Morning! Today, we talk about bioethics, catch up on some reports from ESMO, and wonder aloud and in print over a surprising liquid biopsy bet. The need-to-know this morning Ascendis Pharma reported positive results from a Phase 3 study of  Transcon CNP in children with achondroplasia, the most common form of dwarfism. Children treated with the Ascendis drug grew an average of 1.49 centimeters in a year relative to a placebo, achieving the primary goal of the study.

Bioethics 261
article thumbnail

CV-EMCrit – MCS Minute Series: Differential Gas Exchange on Peripheral Femoral VA ECMO with Trina

EMCrit Project

There is more than one form of differential gas exchange on VA ECMO--remember differential ventilation! EMCrit Project by Katrina Augustin.

115
115
article thumbnail

Could new childhood obesity guidelines fuel eating disorders?

STAT

Good morning! For a limited time, you can get your first three months of a STAT+ subscription for just $5. It’s been about a decade since you could get a footlong from Subway at that price. So it’s a pretty good deal for all the latest news in health and the life sciences, if you ask me. AAP misconstrued research on childhood obesity and eating disorders For the first time in 15 years, the American Academy of Pediatrics last year put forward new clinical guidelines for addressing o

251
251
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

ESMO: Pfizer drug helps cancer patients gain weight

pharmaphorum

Pfizer's anti-GDF-15 antibody ponsegromab was able to achieve weight gain in cancer patients with cachexia in a phase 2 trial presented at ESMO

114
114
article thumbnail

The news from ESMO: An immunotherapy milestone, studying young-onset cancers, and more

STAT

This is the online edition of ESMO in 30 Seconds, a pop-up newsletter from the European Society for Medical Oncology’s annual meeting in Barcelona, Spain. There are no more editions this year, but you can keep up with biopharma news by signing up for STAT’s The Readout newsletter. A status check on immunotherapies It was 10 years ago that Keytruda and Opdivo were approved in their first indications.

227
227
article thumbnail

NHSE currently reviewing Pharmacy First ambitions

The Pharmacist

NHS England (NSHE) is currently reviewing its projected trajectory of how many Pharmacy First, blood pressure and contraception service consultations will be delivered by community pharmacies in 2024/25. And an NSHE spokesperson has revealed that more than half a million Pharmacy First consultations were delivered in the first three months of the service.

article thumbnail

STAT+: What Medicare Advantage enrollment could look like for next year

STAT

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine.  Sign up  to get it in your inbox every Monday. What to make of the 2025 Medicare enrollment season In four weeks, Medicare beneficiaries will be able to sign up for 2025 coverage. And for the roughly 34 million people who are in a Medicare Advantage plan, things likely will look a lot different (and be as confusing as ever), my colleague Tara Bannow repor

Hospitals 214
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Novavax announces availability of Covid-19 vaccine in US pharmacies

Pharmaceutical Business Review

This vaccine is intended for individuals aged 12 and above and is now stocked at pharmacies including CVS Pharmacy, Walgreens, Rite Aid among others. The vaccine has been granted Emergency Use Authorization by the US Food and Drug Administration on 30 August 2024. This authorisation allows for the distribution of Novavax’s updated vaccine, which is the only protein-based option available in the country for the upcoming fall season.

Vaccines 111
article thumbnail

ESMO: NIAGARA backs Imfinzi in bladder cancer, but will FDA?

pharmaphorum

AstraZeneca reveals 'practice changing' data for Imfinzi as peri-operative therapy for bladder cancer, but will the FDA accept the study?

111
111
article thumbnail

Drug-resistant infections are on the rise. so why aren’t we getting any new antibiotics?

The Guardian - Pharmaceutical Industry

World leaders will meet in New York this month to discuss growing antimicrobial resistance as researchers warn the development of replacement drugs is stalling Superbugs ‘could kill 39m people by 2050’ amid rising drug resistance Almost a century on from the groundbreaking discovery of penicillin by Alexander Fleming, his scientific successors are racing to save modern medicine.

106
106
article thumbnail

Changing Faces: Boards of Directors appointments for August 2024

pharmaphorum

Changing Faces: Discover the latest board of directors appointments for Arctoris, BioConnection, Neurocare Group, PureTech Health and more in August 2024. Stay informed and up-to-date with these industry leaders.

108
108
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Strides Pharma subsidiary receives USFDA approval for 60 mg Fluoxetine tablets

Express Pharma

Strides Pharma announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte., Singapore, has received approval from the United States Food & Drug Administration (USFDA) for Fluoxetine Tablets 60 mg. The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Fluoxetine Tablets 60 mg, manufactured by TWi Pharmaceuticals, Inc.

105
105
article thumbnail

Support app for young cancer patients launches in UK

pharmaphorum

Rates of cancer among people aged 24 and below are rising fast, but health systems are often not catering well enough to the specific needs of this age group.A new partnership has been set up between the Ella Dawson Foundation, a UK-based charity for young people with cancer, and digital cancer care company Careology to try to tackle that deficit and improve their treatment and wellbeing.

105
105
article thumbnail

As Biosecure bill advances, drugmakers prepare for prospect of China pivot

BioPharma Dive

Legislation that passed the House of Representatives passed the Biosecure Act last week would forced U.S. biotechs to cut ties with five Chinese contract partners.

98
article thumbnail

Boehringer seeks approval for lung fibrosis drug following Phase III win

Pharmaceutical Technology

The Phase III trial evaluating nerandomilast as a treatment for idiopathic pulmonary fibrosis met its primary endpoint.

98
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Evolving HCP access requires a new connected approach to build engagement

pharmaphorum

Effective engagement with healthcare professionals (HCPs) in the specialty medicine field requires a new connected approach. Find out how to evolve HCP access with tailored strategies.

97
article thumbnail

FDA approves Roche’s Ocrevus Zunovo with Halozyme Enhanze delivery tech

Pharmaceutical Technology

Roche has secured approval from the US Food and Drug Administration for Ocrevus Zunovo with Halozyme's Enhanze drug delivery technology.

98
article thumbnail

From dementia to heart disease: could weight-loss jabs transform chronic conditions? – podcast

The Guardian - Pharmaceutical Industry

They were developed as diabetes drugs, then their potential for promoting significant weight loss became apparent. And now study after study seems to suggest that drugs such as Ozempic and Wegovy could have all sorts of health benefits, leading some scientists to hail them a breakthrough that could transform many chronic diseases of ageing. But what’s the mechanism for these effects and is it caused by more than weight loss?

article thumbnail

Lilly’s EBGLYSS gains FDA approval for patients aged 12 and older

Pharmaceutical Technology

Eli Lilly and Company has announced the FDA approval of EBGLYSS for treating atopic dermatitis in adults and children over 12.

98
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.